Status
Conditions
Treatments
About
Diabetic foot ulcers (DFUs) are a significant complication of diabetes mellitus, associated with poor peripheral circulation, neuropathy, and increased risk of lower-limb amputation. Optimizing peripheral blood flow is critical in the prevention and management of DFUs. Traditional offloading strategies, such as customized foot insoles, have demonstrated efficacy in reducing plantar pressure and promoting ulcer healing.
Electromagnetic field (EMF) therapy is a non-invasive modality that has shown potential in enhancing microcirculation, promoting angiogenesis, and modulating inflammatory processes. Preliminary studies have suggested that EMF may improve peripheral circulation and tissue oxygenation in diabetic patients.
This study aims to investigate the combined effect of EMF therapy and customized foot insoles on peripheral circulation and Ankle-Brachial Pressure Index (ABPI) in patients with diabetic foot ulcers, hypothesizing that this integrated approach may yield superior outcomes compared to standard care.
Full description
Primary Objective:
• To evaluate the effect of EMF therapy combined with customized foot insoles on peripheral circulation in patients with diabetic foot ulcers.
Secondary Objective:
To assess changes in Ankle-Brachial Pressure Index (ABPI) following intervention.
To compare the ulcer healing rates and pain levels between intervention and control groups.
Research Questions
Does the combination of EMF therapy and customized foot insoles improve peripheral circulation in patients with diabetic foot ulcers?
Is there a significant improvement in ABPI in the intervention group compared to control?
What is the effect of the intervention on ulcer healing rates and pain reduction?
Hypotheses
H1: EMF therapy combined with customized foot insoles significantly improves peripheral circulation compared to standard care.
H2: EMF therapy combined with customized foot insoles significantly improves ABPI in patients with diabetic foot ulcers.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
• Diagnosed with Type 2 Diabetes Mellitus.
Exclusion criteria
• Severe peripheral arterial disease (ABPI <0.5).
Primary purpose
Allocation
Interventional model
Masking
79 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
ibrahim ismail Abuzaid, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal